Redsense receives first order from Canada
Redsense Medical AB announces today that the Company has received its first order from Canada. The news follows the recent conclusion of a new distributor agreement for the region, which was disclosed in August.
“It is gratifying to be able to provide hemodialysis patients in Canada with the benefit of a safer treatment. With this order, we are already off to a strong start in this new but important and promising market,” says Patrik Byhmer, CEO of Redsense Medical AB.
The Company is currently in the midst of an effort to open up new markets for the upcoming market launch of the new Redsense Clamp accessory. Redsense conducted a pre-market proof of concept evaluation with the clamp, in cooperation with Toronto University Hospital. A usability evaluation with the clamp is intended to take place later this year.
About Redsense’s products
The Redsense Alarm monitors hemodialysis treatment by detecting the presence of blood via fiber-optic sensing. In an emergency, the Redsense Clamp can clamp the bloodline automatically to stop blood flow immediately as prompted by the alarm unit.
For more information, please contact:
Patrik Byhmer, CEO Redsense Medical AB (publ)
Phone: +46 35 10 60 30
ABOUT REDSENSE MEDICAL
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovationused for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.